HUP0003108A3 - Use of 1-ar(alk)yl-imidazolin-2-one for producing pharmaceutical compositions useful for treating anxiety and stress conditions - Google Patents

Use of 1-ar(alk)yl-imidazolin-2-one for producing pharmaceutical compositions useful for treating anxiety and stress conditions

Info

Publication number
HUP0003108A3
HUP0003108A3 HU0003108A HUP0003108A HUP0003108A3 HU P0003108 A3 HUP0003108 A3 HU P0003108A3 HU 0003108 A HU0003108 A HU 0003108A HU P0003108 A HUP0003108 A HU P0003108A HU P0003108 A3 HUP0003108 A3 HU P0003108A3
Authority
HU
Hungary
Prior art keywords
imidazolin
alk
pharmaceutical compositions
compositions useful
stress conditions
Prior art date
Application number
HU0003108A
Other languages
English (en)
Original Assignee
Elbion Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elbion Ag filed Critical Elbion Ag
Publication of HUP0003108A2 publication Critical patent/HUP0003108A2/hu
Publication of HUP0003108A3 publication Critical patent/HUP0003108A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
HU0003108A 1997-05-23 1998-05-14 Use of 1-ar(alk)yl-imidazolin-2-one for producing pharmaceutical compositions useful for treating anxiety and stress conditions HUP0003108A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19721580A DE19721580A1 (de) 1997-05-23 1997-05-23 Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
PCT/DE1998/001343 WO1998052548A2 (de) 1997-05-23 1998-05-14 Verwendung von 1-ar(alk)yl-imidazolin-2-one zur behandlung von angst- und spannungszuständen
US09/079,802 US5994347A (en) 1997-05-23 1998-05-15 For a process for treatment of anxiety and tension

Publications (2)

Publication Number Publication Date
HUP0003108A2 HUP0003108A2 (hu) 2001-05-28
HUP0003108A3 true HUP0003108A3 (en) 2001-07-30

Family

ID=26036759

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003108A HUP0003108A3 (en) 1997-05-23 1998-05-14 Use of 1-ar(alk)yl-imidazolin-2-one for producing pharmaceutical compositions useful for treating anxiety and stress conditions

Country Status (25)

Country Link
US (1) US5994347A (hu)
EP (1) EP0979083B1 (hu)
JP (1) JP4838403B2 (hu)
CN (1) CN1150901C (hu)
AR (1) AR012746A1 (hu)
AT (1) ATE246926T1 (hu)
AU (1) AU745536B2 (hu)
BG (1) BG63378B1 (hu)
BR (1) BR9809666A (hu)
CA (1) CA2291075C (hu)
DE (2) DE19721580A1 (hu)
DK (1) DK0979083T3 (hu)
ES (1) ES2205516T3 (hu)
HU (1) HUP0003108A3 (hu)
IL (1) IL132652A0 (hu)
NO (1) NO325346B1 (hu)
NZ (1) NZ500849A (hu)
PL (1) PL193589B1 (hu)
PT (1) PT979083E (hu)
RU (1) RU2203055C2 (hu)
SK (1) SK284258B6 (hu)
TR (1) TR199902815T2 (hu)
TW (1) TW579294B (hu)
WO (1) WO1998052548A2 (hu)
ZA (1) ZA984197B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US20050070537A1 (en) 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
AU2004255414A1 (en) * 2003-07-11 2005-01-20 Boehringer Ingelheim Vetmedica Gmbh Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
AU2005272802B2 (en) 2004-08-11 2009-07-02 Intercontinental Great Brands Llc Sensate compositions and delivery systems therefor
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
DE19532668A1 (de) * 1995-09-05 1997-03-06 Dresden Arzneimittel Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung
US5869481A (en) * 1995-09-05 1999-02-09 Arzneitmittelwerk Dresden G.M.B.H. Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making

Also Published As

Publication number Publication date
EP0979083A2 (de) 2000-02-16
SK158499A3 (en) 2001-03-12
TW579294B (en) 2004-03-11
DK0979083T3 (da) 2003-12-01
NO995300D0 (no) 1999-10-29
NO995300L (no) 1999-10-29
CA2291075C (en) 2006-04-04
CN1150901C (zh) 2004-05-26
ES2205516T3 (es) 2004-05-01
JP2001525829A (ja) 2001-12-11
HUP0003108A2 (hu) 2001-05-28
TR199902815T2 (xx) 2000-08-21
US5994347A (en) 1999-11-30
PL337090A1 (en) 2000-07-31
ZA984197B (en) 1998-06-24
WO1998052548A3 (de) 1999-04-22
SK284258B6 (sk) 2004-12-01
IL132652A0 (en) 2001-03-19
DE59809285D1 (de) 2003-09-18
BG103859A (en) 2000-07-31
AU745536B2 (en) 2002-03-21
RU2203055C2 (ru) 2003-04-27
BR9809666A (pt) 2000-07-11
AU8332698A (en) 1998-12-11
EP0979083B1 (de) 2003-08-13
PL193589B1 (pl) 2007-02-28
NZ500849A (en) 2001-09-28
CN1260717A (zh) 2000-07-19
AR012746A1 (es) 2000-11-08
WO1998052548A2 (de) 1998-11-26
PT979083E (pt) 2003-12-31
DE19721580A1 (de) 1998-11-26
ATE246926T1 (de) 2003-08-15
NO325346B1 (no) 2008-04-07
JP4838403B2 (ja) 2011-12-14
BG63378B1 (bg) 2001-12-29
CA2291075A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
HUP0000478A3 (en) Substituted cyclic amine as metalloprotease inhibitors and use of them for producing pharmaceutical compositions
PL335168A1 (en) Compositions for and methods of reducing intracocular hypertension
AP2001002183A0 (en) Ethanolate of zithromycin process for manufacture and pharmaceutical compositions thereof
BR9710182A (pt) Embalagem tipo ampola aparelho e processo para fabricar uma embalagem tipo ampola e uso de uma embalagem tipo ampola
DE59905323D1 (de) Verfahren zur herstellung von methylendi(phenylamin) und methylendi (phenylisocyanat)
HUP0003133A2 (en) Ace-inhibitor nitric salts and use of them for producing pharmaceutical compositions
HUP0100568A3 (en) 11beta-halogen-7alpha-substituted estratrienes, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
PT1039909E (pt) Metodo de producao e composicao de uma preparacao oral de itraconazole
US5656608B1 (en) Amino acid compositions and methods of treatment using same
GB2343117B (en) Benzimidazole pharmaceutical composition and process of preparation
GB2327190B (en) Process for the preparation of depilatory compositions and their use
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
HUP0100170A3 (en) N-benzyl-3-indenylacetamides derivatives and use of them for producing pharmaceutical compositions for treating neoplasia
ATE308365T1 (de) Zusammensetzungen zur oralen verabreichung von taxanen und deren verwendung
IL131850A0 (en) Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1, 2, 3, 4-tetrahydro-isoquinolin-6-yl)-amide
NO993807L (no) Fremgangsmaate og apparatur for fremstilling av hydrolysater av krill
HUP0003108A3 (en) Use of 1-ar(alk)yl-imidazolin-2-one for producing pharmaceutical compositions useful for treating anxiety and stress conditions
PL321204A1 (en) Compositions for peroxiding creatine fibres and method of using such compositions
EE9900578A (et) Tisoksaniidi ja nitasoksaniidi farmatseutilised kompositsioonid
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
IL120128A0 (en) Compositions for the treatment of androgenetic alopecia and hirsutism
IL132737A0 (en) Method of producing tiazofurin and other c-nucleosides
HUP9801646A3 (en) Process for the preparation of 2-chlor-benzimidazole derivatives and 1,3-dihidrobenzimidazol(thi)ones and preparation of the latters
DE9409972U1 (de) Keramisches Befestigungssystem zur Kapselbandrekonstruktion am Knie- und Schultergelenk
HU9802142D0 (en) Use of na+/h+ -ion-exchange inhibitors for producing pharmaceutical compositions for treating and profilacting diseases of the central nerve system

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: BOEHRINGER INGELHEIM VETMEDICA GMBH, DE

Free format text: FORMER OWNER(S): ARZNEIMITTELWERK DRESDEN GMBH., DE; ELBION AG, DE

FD9A Lapse of provisional protection due to non-payment of fees